Chronic phase Philadelphia chromosome positive chronic myelocytic leukemia

Chronic phase Philadelphia chromosome-positive chronic myelocytic leukemia (also termed chronic myeloid leukemia) is an indolent myeloproliferative neoplasm originating from hematologic stem cells in the bone marrow Pathophysiologically, it is defined by the reciprocal chromosomal translocation t(9;22)(q34;q11), creating the Philadelphia chromosome and an abnormal BCR::ABL1 fusion gene encoding a constitutively active tyrosine kinase that drives uncontrolled myeloid proliferation In this initial...

Pathophysiologically, it is defined by the reciprocal chromosomal translocation t(9;22)(q34;q11), creating the Philadelphia chromosome and an abnormal BCR::ABL1 fusion gene encoding a constitutively active tyrosine kinase that drives uncontrolled myeloid proliferation Primarily diagnosed in adults, the disease may present with fatigue, splenomegaly, or systemic symptoms, but it is frequently identified incidentally on routine blood evaluations

In this initial chronic stage, patients typically exhibit leukocytosis with preserved cell maturation and fewer than 10% immature blasts in both peripheral blood and bone marrow